Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression


Creative Commons License

Trautmann A., Seide S., Lipska-Zietkiewicz B. S., ÖZALTIN F., Szczepanska M., Azocar M., ...More

PEDIATRIC NEPHROLOGY, vol.38, no.5, pp.1499-1511, 2023 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 5
  • Publication Date: 2023
  • Doi Number: 10.1007/s00467-022-05762-4
  • Journal Name: PEDIATRIC NEPHROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.1499-1511
  • Keywords: Nephrotic syndrome, Steroid resistance, SRNS, Children, Antiproteinuric treatment, FOCAL SEGMENTAL GLOMERULOSCLEROSIS, CONVERTING ENZYME-INHIBITORS, SPONTANEOUS REMISSION, ANGIOTENSIN BLOCKADE, CYCLOSPORINE-A, TACROLIMUS, ENALAPRIL, THERAPY, TRIAL, PROTEINURIA
  • Istanbul University Affiliated: No

Abstract

Background The aim of the current PodoNet registry analysis was to evaluate the outcome of steroid-resistant nephrotic syndrome (SRNS) in children who were not treated with intensified immunosuppression (IIS), focusing on the potential for spontaneous remission and the role of angiotensin blockade on proteinuria reduction.